San Francisco, CA – According to filings with the U.S. Securities and Exchange Commission, Invitae is raising $19,679,155.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Sean George played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Invitae

Invitae is a leader in medical genetic testing, driving genetic information into mainstream medicine to improve healthcare for billions of people. Invitae is aggregating the world’s medical genetic tests into a single service with higher quality, faster turnaround time, and lower prices. By driving down the cost of genetic testing we make it affordable and accessible to everyone who can benefit. Our dedication to our mission is fueling explosive growth, with both our test volume and revenue doubling year-over-year for the past four years. Our team has grown from 300 employees to more than 1,000 in just two years and we have helped hundreds of thousands of patients get the answers they need.

To learn more about Invitae, visit http://www.invitae.com/

Contact:
Sean George, Chief Executive Officer
415-374-7782

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved